Related Experiment Video
Updated: Jul 1, 2026

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
Management of highly sensitized patients: capitol medical center experience
1Capitol Medical Center, Quezon City, Philippines.
Insights
Highly sensitized patients can now receive kidney transplants. A desensitization protocol using Rituximab, IVIG, and plasmapheresis effectively prepared patients with anti-HLA antibodies for successful transplantation.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Highly sensitized patients with anti-HLA antibodies face challenges in kidney transplantation due to cross-match positivity.
- Longer waiting times for cadaveric donors are common for these patients.
- Existing strategies aim to overcome cross-match positivity for successful transplantation.
Purpose of the Study:
- To evaluate the efficacy of a desensitization protocol in preparing highly sensitized patients for kidney transplantation.
- To report clinical experience with Rituximab-based desensitization combined with IVIG and/or plasmapheresis.
Main Methods:
- A desensitization protocol was employed.
- The protocol included the monoclonal antibody Rituximab.
- Intravenous immunoglobulin (IVIG) and/or plasmapheresis were used as complementary treatments.
Main Results:
- The desensitization protocol successfully prepared highly sensitized patients for kidney transplantation.
- The combination of Rituximab with IVIG and/or plasmapheresis addressed cross-match positivity.
- Successful kidney transplantation was achieved in these challenging cases.
Conclusions:
- Desensitization protocols, particularly those involving Rituximab, are effective in enabling kidney transplantation for highly sensitized patients.
- This approach overcomes barriers posed by anti-HLA antibodies and cross-match positivity.
- The study highlights a viable strategy to improve transplant access for patients with high immunological risk.
Abstract:
Highly sensitized patients with elevated anti-HLA antibodies have difficulty to get a living donor due to cross-match positivity and longer waiting times for cadaveric donor transplantation. In this regard, several studies have been made to abrogate cross-match positivity for a possible successful kidney transplantation. In this article, we report our experience, using a desensitization protocol with Rituximab monoclonal antibody complemented with intravenous immunoglubulin and/or plasmapheresis, to prepare highly sensitized patients for successful kidney transplantation.
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Acute Respiratory Failure-III
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Imaging Studies for Cardiovascular System V: CT